Literature DB >> 19343780

Titanium dioxide nanotubes enhance bone bonding in vivo.

Lars M Bjursten1, Lars Rasmusson, Seunghan Oh, Garrett C Smith, Karla S Brammer, Sungho Jin.   

Abstract

Implant topography is critical to the clinical success of bone-anchored implants, yet little is known how nano-modified implant topography affects osseointegration. We investigate the in vivo bone bonding of two titanium implant surfaces: titanium dioxide (TiO(2)) nanotubes and TiO(2) gritblasted surfaces. In previous in vitro studies, the topography of the TiO(2) nanotubes improved osteoblast proliferation and adhesion compared with gritblasted titanium surfaces. After four weeks of implantation in rabbit tibias, pull-out testing indicated that TiO(2) nanotubes significantly improved bone bonding strength by as much as nine-fold compared with TiO(2) gritblasted surfaces. Histological analysis confirmed greater bone-implant contact area, new bone formation, and calcium and phosphorus levels on the nanotube surfaces. It is anticipated that further studies will contribute to a better understanding of the effect of implant nanotopography on in vivo bone formation and bonding strength. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19343780     DOI: 10.1002/jbm.a.32463

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  61 in total

1.  RGD peptide immobilized on TiO2 nanotubes for increased bone marrow stromal cells adhesion and osteogenic gene expression.

Authors:  Xin Cao; Wei-qiang Yu; Jing Qiu; Yan-fang Zhao; Yi-lin Zhang; Fu-qiang Zhang
Journal:  J Mater Sci Mater Med       Date:  2011-12-06       Impact factor: 3.896

2.  Genetic responses to nanostructured calcium-phosphate-coated implants.

Authors:  R Jimbo; Y Xue; M Hayashi; H O Schwartz-Filho; M Andersson; K Mustafa; A Wennerberg
Journal:  J Dent Res       Date:  2011-09-20       Impact factor: 6.116

Review 3.  Biomaterials and interface with bone.

Authors:  K Anselme
Journal:  Osteoporos Int       Date:  2011-06       Impact factor: 4.507

4.  Electrically polarized TiO2 nanotubes on Ti implants to enhance early-stage osseointegration.

Authors:  Amit Bandyopadhyay; Anish Shivaram; Indranath Mitra; Susmita Bose
Journal:  Acta Biomater       Date:  2019-07-19       Impact factor: 8.947

5.  Differential responses of osteoblast lineage cells to nanotopographically-modified, microroughened titanium-aluminum-vanadium alloy surfaces.

Authors:  Rolando A Gittens; Rene Olivares-Navarrete; Taylor McLachlan; Ye Cai; Sharon L Hyzy; Jennifer M Schneider; Zvi Schwartz; Kenneth H Sandhage; Barbara D Boyan
Journal:  Biomaterials       Date:  2012-09-16       Impact factor: 12.479

6.  Increased preosteoblast adhesion and osteogenic gene expression on TiO2 nanotubes modified with KRSR.

Authors:  ShengJun Sun; WeiQiang Yu; YiLin Zhang; FuQiang Zhang
Journal:  J Mater Sci Mater Med       Date:  2013-01-31       Impact factor: 3.896

7.  Direct comparison of additively manufactured porous titanium and tantalum implants towards in vivo osseointegration.

Authors:  Amit Bandyopadhyay; Indranath Mitra; Anish Shivaram; Nairanjana Dasgupta; Susmita Bose
Journal:  Addit Manuf       Date:  2019-05-01

8.  In Vivo Response of Laser Processed Porous Titanium Implants for Load-Bearing Implants.

Authors:  Amit Bandyopadhyay; Anish Shivaram; Solaiman Tarafder; Himanshu Sahasrabudhe; Dishary Banerjee; Susmita Bose
Journal:  Ann Biomed Eng       Date:  2016-06-15       Impact factor: 3.934

9.  Tantalum coating on TiO2 nanotubes induces superior rate of matrix mineralization and osteofunctionality in human osteoblasts.

Authors:  Christine J Frandsen; Karla S Brammer; Kunbae Noh; Gary Johnston; Sungho Jin
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-01-14       Impact factor: 7.328

10.  Effects of TiO2 nanotube layers on RAW 264.7 macrophage behaviour and bone morphogenetic protein-2 expression.

Authors:  S J Sun; W Q Yu; Y L Zhang; X Q Jiang; F Q Zhang
Journal:  Cell Prolif       Date:  2013-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.